Diala F Hamade, Alexis Espinal, Jian Yu, Brian J Leibowitz, Renee Fisher, Wen Hou, Donna Shields, Jan-Peter van Pijkeren, Amitava Mukherjee, Michael W Epperly, Anda M Vlad, Lan Coffman, Hong Wang, M Saiful Huq, Ravi Patel, Jason Huang, Joel S Greenberger
Oral administration (gavage) of a second-generation probiotic, Lactobacillus reuteri (L. reuteri), that releases interleukin-22 (LR-IL-22) at 24 h after total-body irradiation (TBI) mitigates damage to the intestine. We determined that LR-IL-22 also mitigates partial-body irradiation (PBI) and whole-abdomen irradiation (WAI). Irradiation can be an effective treatment for ovarian cancer, but its use is limited by intestinal toxicity. Strategies to mitigate toxicity are important and can revitalize this modality to treat ovarian cancer...
July 1, 2022: Radiation Research